Programmed cell death (PDCD) Inhibitors
Items 11 to 17 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PAC 1 | 315183-21-2 | sc-203174 sc-203174A | 10 mg 50 mg | $132.00 $536.00 | 1 | |
PAC-1 induces caspase activation, potentially influencing Pdcd-7's role in the apoptotic pathway. | ||||||
Apoptosis Activator VII, Apoptozole | 1054543-47-3 | sc-221257 | 10 mg | $243.00 | 1 | |
As an apoptosis inducer, it may counteract or influence pathways where Pdcdis involved. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets multiple kinases involved in cell proliferation and angiogenesis. It may inhibit Pdcd-4 expression by modulating signaling pathways associated with cell growth and survival. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor that interferes with the epidermal growth factor receptor signaling pathway. It may downregulate Pdcd-4 expression as a consequence of its action on this pathway. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is a kinase inhibitor specific for EGFR. It may impact Pdcd-4 expression through its modulation of EGFR signaling, potentially influencing cell proliferation and survival. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that targets BCR-ABL, c-KIT, and PDGFR. It may alter Pdcd-4 expression indirectly through its effects on these signaling pathways. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is a platinum-containing chemotherapy drug that causes DNA damage. It may influence Pdcd-4 expression as part of its broader effects on cell cycle progression and apoptosis. | ||||||